Multicenter randomized phase II study comparing docetaxel plus curcumin versus docetaxel plus placebo in first‐line treatment of metastatic castration‐resistant prostate cancer

by Judith Passildas‐Jahanmohan, Jean‐Christophe Eymard, Mélanie Pouget, Fabrice Kwiatkowski, Isabelle Van Praagh, Laurent Savareux, Marc Atger, Xavier Durando, Catherine Abrial, Damien Richard, Angeline Ginzac Couvé, Emilie Thivat, Brigitte Monange, Philippe Chollet, Hakim Mahammedi
Published 2021-04-01